Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

All News

Archives

Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems

Endologix LLC Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System

John McDermott Steps Down as Chief Executive Officer of Endologix LLC

Endologix LLC Completes Patient Enrollment in the ELEVATE IDE Clinical Study

Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)